4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial.

Autor: Forrest JK; Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address: john.k.forrest@yale.edu., Deeb GM; University of Michigan Health Systems-University Hospital, Ann Arbor, Michigan, USA., Yakubov SJ; OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA., Gada H; University of Pittsburgh Medical Center, Harrisburg, Pennsylvania, USA., Mumtaz MA; University of Pittsburgh Medical Center, Harrisburg, Pennsylvania, USA., Ramlawi B; Lankenau Heart Institute, Philadelphia, Pennsylvania, USA., Bajwa T; Aurora St Luke's Medical Center, Milwaukee, Wisconsin, USA., Teirstein PS; Scripps Clinic, La Jolla, California, USA., Tchétché D; Clinique Pasteur, Toulouse, France., Huang J; Medtronic, Mounds View, Minnesota, USA., Reardon MJ; Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
Jazyk: angličtina
Zdroj: Journal of the American College of Cardiology [J Am Coll Cardiol] 2023 Nov 28; Vol. 82 (22), pp. 2163-2165. Date of Electronic Publication: 2023 Oct 24.
DOI: 10.1016/j.jacc.2023.09.813
Databáze: MEDLINE